My watch list  

‘Biased’ opioids could yield safer pain relief

Nearly all of the roughly 64,000 Americans who died from opioid overdoses in 2016 succumbed because their breathing shut down, triggered by the effects of the drugs on important receptors in the brain stem. When they are activated, μ-opioid receptors potently relieve pain. They also control respiration. Now, for the first time, a drug that in binding these receptors causes powerful pain relief with less respiratory suppression is being evaluated for marketing approval by the Food and Drug Administration. Biotech company Trevana’s drug, oliceridine, acts as a μ-opioid receptor to activate a pain-relieving signaling pathway with less triggering of a separate path that leads to depressed breathing. Oliceridine is the first so-called “biased opioid” to emerge from human clinical trials. There will certainly be more: In a paper published in Cell this week, scientists at the Scripps Research Institute in Jupiter, Florida, have rigorously demonstrated for the first time in mice that the more biased a compound is toward activating the pain-relieving pathway, the less it suppresses breathing.

Authors:   Meredith Wadman
Journal:   Science
Volume:   358
edition:   6365
Year:   2017
Pages:   847
DOI:   10.1126/science.358.6365.847
Publication date:   17-Nov-2017
Facts, background information, dossiers
  • marketing
  • food
  • drugs
More about Science International / AAAS
  • Publications

    Random number generators go public

    On 10 July, researchers in Chile will unveil an online public random number service. Later in July, the U.S. National Institute of Standards and Technology (NIST) will launch its Randomness Beacon as a permanent service, upgrading a pilot program that began in 2013. Brazil, too, is planning ... more

    When the cure kills—CBD limits biodiversity research

    The Convention on Biological Diversity (CBD) commits its 196 nation parties to conserve biological diversity, use its components sustainably, and share fairly and equitably the benefits from the utilization of genetic resources. The last of these objectives was further codified in the Conve ... more

    See-through solar cells could power offices

    Solar windows turn some of the light shining through into electricity. They've been on the market for years. But many of these windows absorb some visible light, leaving them with a reddish or brownish hue, a trait frowned on by architects. Now, new versions are on the way that absorb invis ... more

  • News

    Merck Named a Top Employer by Science Magazine

    Merck announced it was ranked fourth among biotechnology and pharmaceutical companies worldwide by Science magazine, a leading peer-reviewed international scientific publication. This ranking marks the fourth year in a row Merck was named one of the top 20 employers in the healthcare and li ... more

    Merck Named as Top Employer by Science Magazine

    Merck announced it was named number 11 among the top 20 employers in the global biopharmaceutical industry by Science magazine, a leading peer-reviewed international scientific publication. This is the third year in a row that Merck, including EMD Serono in the United States, has been named ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE